Shandong Sanyuan Biotechnology Co.,Ltd.

Shenzhen Stock Exchange 301206.SZ

Shandong Sanyuan Biotechnology Co.,Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 639.18 M

Shandong Sanyuan Biotechnology Co.,Ltd. Shareholders' Equity is USD 639.18 M for the year ending December 31, 2023, a -4.54% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Shandong Sanyuan Biotechnology Co.,Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 669.60 M, a 307.02% change year over year.
  • Shandong Sanyuan Biotechnology Co.,Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 164.51 M, a 110.59% change year over year.
  • Shandong Sanyuan Biotechnology Co.,Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 78.12 M, a 56.25% change year over year.
  • Shandong Sanyuan Biotechnology Co.,Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 50.00 M, a 91.54% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
Loading...
SV Wall Street
Shenzhen Stock Exchange: 301206.SZ

Shandong Sanyuan Biotechnology Co.,Ltd.

CEO Mr. Baohua Cheng
IPO Date Feb. 10, 2022
Location China
Headquarters No.89, Zhangfu Road
Employees 427
Sector Healthcare
Industries
Description

Shandong Sanyuan Biotechnology Co., Ltd. engages in the research and development, production, and sales of erythritol and compound sugar products in China. Its products are used in table sugar, flavored sugar, beverages; candy, chocolate food; baked food; health food; pharmaceutical products; cosmetic products; chemical products; and other applications. The company exports its products to Europe, the United States, East Asia, Southeast Asia, Australia, New Zealand, and Africa. Shandong Sanyuan Biotechnology Co., Ltd. was founded in 2007 and is headquartered in Binzhou, China.

StockViz Staff

February 2, 2025

Any question? Send us an email